Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121942084 | 12194208 | 4 | F | 2009 | 20160409 | 20160321 | 20160805 | EXP | US-GLENMARK PHARMACEUTICALS EUROPE LIMITED-2016GMK022313 | GLENMARK | 0.00 | Y | 0.00000 | 20160804 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121942084 | 12194208 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 1200 MG, TID | N | 17150480 | 77662 | 1200 | MG | TABLET | TID | ||||
| 121942084 | 12194208 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | N | 77662 | TABLET | ||||||||||
| 121942084 | 12194208 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | N | 77662 | TABLET | ||||||||||
| 121942084 | 12194208 | 4 | C | METHADONE | METHADONE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 121942084 | 12194208 | 5 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 121942084 | 12194208 | 6 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 121942084 | 12194208 | 7 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 121942084 | 12194208 | 8 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 121942084 | 12194208 | 9 | C | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 121942084 | 12194208 | 10 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 121942084 | 12194208 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 121942084 | 12194208 | 12 | C | MYRBETRIQ | MIRABEGRON | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121942084 | 12194208 | 1 | Nerve injury |
| 121942084 | 12194208 | 2 | Neuralgia |
| 121942084 | 12194208 | 3 | Groin pain |
| 121942084 | 12194208 | 4 | Product used for unknown indication |
| 121942084 | 12194208 | 5 | Product used for unknown indication |
| 121942084 | 12194208 | 6 | Product used for unknown indication |
| 121942084 | 12194208 | 7 | Product used for unknown indication |
| 121942084 | 12194208 | 8 | Product used for unknown indication |
| 121942084 | 12194208 | 9 | Product used for unknown indication |
| 121942084 | 12194208 | 10 | Product used for unknown indication |
| 121942084 | 12194208 | 11 | Product used for unknown indication |
| 121942084 | 12194208 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121942084 | 12194208 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121942084 | 12194208 | Amnesia | |
| 121942084 | 12194208 | Cognitive disorder | |
| 121942084 | 12194208 | Loss of employment | |
| 121942084 | 12194208 | Neoplasm progression | |
| 121942084 | 12194208 | Product substitution issue | |
| 121942084 | 12194208 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121942084 | 12194208 | 1 | 20090829 | 20150901 | 0 | |
| 121942084 | 12194208 | 4 | 2009 | 0 | ||
| 121942084 | 12194208 | 5 | 2009 | 0 | ||
| 121942084 | 12194208 | 6 | 2009 | 0 | ||
| 121942084 | 12194208 | 7 | 2009 | 0 | ||
| 121942084 | 12194208 | 8 | 2009 | 0 | ||
| 121942084 | 12194208 | 9 | 2015 | 0 | ||
| 121942084 | 12194208 | 10 | 2015 | 0 | ||
| 121942084 | 12194208 | 11 | 2015 | 0 |